Correction of hyperglycemia in diabetic mice transplanted with reversibly immortalized pancreatic beta cells controlled by the tet-on regulatory system.
about
P1343
Sox17 regulates insulin secretion in the normal and pathologic mouse β cellDifferential gene expression in human hepatocellular carcinoma Hep3B cells induced by apoptosis-related gene BNIPL-2Overexpression of monocarboxylate transporter-1 (SLC16A1) in mouse pancreatic β-cells leads to relative hyperinsulinism during exerciseVascular endothelial growth factor coordinates islet innervation via vascular scaffolding.Identification of small-molecule inducers of pancreatic beta-cell expansionActivation of PyMT in beta cells induces irreversible hyperplasia, but oncogene-dependent acinar cell carcinomas when activated in pancreatic progenitors.Inhibition of pancreatic β-cell Ca2+/calmodulin-dependent protein kinase II reduces glucose-stimulated calcium influx and insulin secretion, impairing glucose tolerance.Activated FoxM1 attenuates streptozotocin-mediated β-cell death.Neurogenin3 inhibits proliferation in endocrine progenitors by inducing Cdkn1a.Conditional and specific NF-kappaB blockade protects pancreatic beta cells from diabetogenic agents.Gαi/o-coupled receptor signaling restricts pancreatic β-cell expansionReversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells.Connective tissue growth factor acts within both endothelial cells and beta cells to promote proliferation of developing beta cells.Connective tissue growth factor modulates adult β-cell maturity and proliferation to promote β-cell regeneration in miceMacrophages are essential for CTGF-mediated adult β-cell proliferation after injury.Enhanced expression of VEGF-A in β cells increases endothelial cell number but impairs islet morphogenesis and β cell proliferation.Differential regulation of embryonic and adult β cell replication.Activation of FoxM1 Revitalizes the Replicative Potential of Aged β-Cells in Male Mice and Enhances Insulin Secretion.Establishment of an artificial beta-cell line expressing insulin under the control of doxycycline.Chapter 4. Evaluating the control of mRNA decay in fission yeast.A Tet-on and Cre-loxP Based Genetic Engineering System for Convenient Recycling of Selection Markers in Penicillium oxalicum.Over-expression of Slc30a8/ZnT8 selectively in the mouse α cell impairs glucagon release and responses to hypoglycemia.mTORC1 activation regulates beta-cell mass and proliferation by modulation of cyclin D2 synthesis and stabilityMolecular Genetic Regulation of Slc30a8/ZnT8 Reveals a Positive Association With Glucose Tolerance.Conditional hypovascularization and hypoxia in islets do not overtly influence adult β-cell mass or function.p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion.Disallowance of Acot7 in β-Cells Is Required for Normal Glucose Tolerance and Insulin Secretion.Inhibition of DYRK1A and GSK3B induces human β-cell proliferation.Decreased STARD10 Expression Is Associated with Defective Insulin Secretion in Humans and MiceTransient neonatal diabetes mellitus gene Zac1 impairs insulin secretion in mice through Rasgrf1Recovery from diabetes in mice by beta cell regeneration.
P2860
Q27315224-9977DBB9-D474-41FE-A120-7AE8E7BD07D7Q28258914-F10093DB-10EC-4944-81F8-B0CE07C108A4Q28513468-0FAC9928-C53F-456F-92A8-21D25963DF45Q30574301-9B417367-F180-46B7-B4B6-C9422512BFD1Q33402400-4B7087E1-40F1-4D70-931F-D040828F6737Q33509298-5C9781DA-F029-4065-B73C-3504B9F7A17FQ33556105-DFEEB5AE-8264-4363-B4AC-BEAEBDED931FQ34131699-ADE45A2F-CEBE-49B7-960B-99F4AB662722Q34472119-67F0B275-0A30-4F86-B454-DCC106BDFD66Q34596884-758CA852-6E38-4FE5-8330-F6058E54131AQ35157007-9913B9E8-9187-4106-858E-19694B62A759Q35163469-541C4F1F-2C3A-4FB1-BEF4-D3B316158826Q35217006-F898AB39-692E-4F23-BD0B-8BE80BB0E6C7Q35220576-823727C6-6B35-446C-B2C5-2DF60057E5F6Q35929489-E1282222-D2C7-4497-BEB2-2F899085ADB5Q36081721-ED4ECEDD-4B46-4623-827A-E3A6285B701DQ36116212-EB739AD3-B9C6-4E71-B336-5349B11797FFQ36186281-B61B2B32-A774-4C36-8C44-4B267FC05377Q36316148-B9AECE65-4E60-4A49-9179-84D8B0D62668Q36623382-003A0FEC-A3EF-43C8-8EE0-35BC86C9071EQ36789161-CC1D412B-05D5-48C7-8978-81F814B7F16EQ37073892-DCB76963-19F0-497B-B44B-0ACA95784AEAQ37134416-90828DC5-59C8-4632-9AC3-01F4BB95E92DQ37198275-69FB9E66-09D1-40AB-BFE7-73604B49492CQ37333451-C4CB2DB0-5A3F-4C18-95A2-175BD8D051E4Q38788371-943A5C86-2CC7-45DD-AD4B-9E613FAD07A7Q38795298-B4AB13B0-C1E4-4A8B-AEA4-420C0A69C243Q38950360-04D1792B-F1DA-4069-B42E-42A65E5FE0E6Q38993206-559A87C1-3595-4D7B-919B-61E15F39E338Q39355907-20653918-8CE8-4F14-8183-B4C3B9B2FEB6Q42408079-ADB541A1-7C53-435D-A261-74201C6618FB
P2860
Correction of hyperglycemia in diabetic mice transplanted with reversibly immortalized pancreatic beta cells controlled by the tet-on regulatory system.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Correction of hyperglycemia in ...... the tet-on regulatory system.
@en
type
label
Correction of hyperglycemia in ...... the tet-on regulatory system.
@en
prefLabel
Correction of hyperglycemia in ...... the tet-on regulatory system.
@en
P2093
P1433
P1476
Correction of hyperglycemia in ...... the tet-on regulatory system.
@en
P2093
Berkovich I
Christofori G
Compagni A
Fleischer N
Milo-Landesman D
P304
P4510
P577
2001-01-01T00:00:00Z